Verastem Reports $0.50 Q4 Loss, Revenue Climbs to $17.5M
Verastem posted a Q4 adjusted loss of $0.50 per share versus a $0.49 expected loss, improving from a $1.33 loss a year ago and missing estimates by 2.04%. Revenue reached $17.54 million, topping forecasts by 0.2% and marking its first quarter of positive revenue.
1. Q4 Financial Results
Verastem reported an adjusted Q4 loss of $0.50 per share, missing consensus by 2.04%, while revenue totaled $17.54 million, topping forecasts by 0.2%.
2. Year-Over-Year and Stock Trends
The $0.50 loss improved from a $1.33-per-share deficit in Q4 2024, marking the first quarter of revenue after zero sales a year earlier; shares have declined 26.4% year to date.
3. Analyst Estimates and Outlook
Consensus EPS for the coming quarter stands at a $0.46 loss on $22.8 million revenue, with full-year estimates at a $1.86 loss and $134.45 million revenue; near-term performance may hinge on management commentary and estimate revisions.